International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age
- 1 May 2006
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (8) , 1113-1119
- https://doi.org/10.1016/j.ejca.2005.11.031
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Favorable Prognosis for Patients 12 to 18 Months of Age With Stage 4 Nonamplified MYCN Neuroblastoma: A Children's Cancer Group StudyJournal of Clinical Oncology, 2005
- Epidemiology and genetics of childhood cancerOncogene, 2004
- Neuroblastoma: biological insights into a clinical enigmaNature Reviews Cancer, 2003
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Identification of Subsets of Neuroblastomas by Combined Histopathologic and N-myc AnalysisJNCI Journal of the National Cancer Institute, 1995
- Neuroblastoma: a clinical challenge and biologic puzzleCA: A Cancer Journal for Clinicians, 1995
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease StageScience, 1984
- Asymptotically Efficient Rank Invariant Test ProceduresJournal of the Royal Statistical Society. Series A (General), 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958